Non-invasive pXRF technique for identifying pigments in multilayered artistic paintings
Conservar Património · 2026
DOI: 10.14568/cp41924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Conservar Património, 2026. Verfasst von Rosario Blanc und 2 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Portable X-ray fluorescence (pXRF) is a powerful analytical tool; however, its application to the analysis of complex pigment mixtures and multilayered artistic paintings − particularly ternary and quaternary systems distributed across one or more layers − still presents significant challenges. This study investigates the effectiveness of pXRF in detecting specific pigments, such as azurite, cinnabar, and lead white, within complex mixtures and overlapping stratigraphic layers, which are typical features of historical paintings and polychrome sculptures. Cadmium yellow, a pigment commonly used in later periods as overpainting, was also successfully identified, providing insights into the usefulness of pXRF for testing on historical artworks, even when dealing with later additions or restorations. The insights gained from these experimental replicas were subsequently applied to the analysis of two historical paintings selected as case studies, in which the target pigments were found to be heterogeneously distributed and mixed in varying proportions.
Zitieren
APA
Blanc, R., Manzano, E., & Vílchez, J. L. (2026). Non-invasive pXRF technique for identifying pigments in multilayered artistic paintings. Conservar Património. https://doi.org/10.14568/cp41924
Vancouver
Blanc R, Manzano E, Vílchez JL. Non-invasive pXRF technique for identifying pigments in multilayered artistic paintings. Conservar Património. 2026. doi:10.14568/cp41924
BibTeX
@article{Blanc2026,
author = {Blanc, Rosario and Manzano, Eloisa and Vílchez, José Luis},
title = {Non-invasive pXRF technique for identifying pigments in multilayered artistic paintings},
journal = {Conservar Património},
year = {2026},
doi = {10.14568/cp41924}
}
EUVIMED